Therapeutic monoclonal antibodies in combination with pomalidomide can overcome refractoriness to both agents in multiple myeloma: A case-based approach.
Baertsch MA et al. Hematol Oncol. 2017 Aug 25. doi: 10.1002/hon.2473. [Epub ahead of print].
Evolutionary biology of high-risk multiple myeloma.
Pawlyn C et al. Nat Rev Cancer. 2017 Aug 24;17(9):543-556. doi: 10.1038/nrc.2017.63.
Comprehensive Evaluation of the Revised International Staging System in Multiple Myeloma Patients Treated with Novel Agents as a Primary Therapy.
Cho H et al. Am J Hematol. 2017 Aug 22. doi: 10.1002/ajh.24891. [Epub ahead of print].
AYA-Myeloma: Real-World, Single-Center Experience Over Last 5 Years.
Yanamandra U et al. J Adolesc Young Adult Oncol. 2017 Aug 22. doi: 10.1089/jayao.2017.0034. [Epub ahead of print].
Distress and unmet needs during treatment and quality of life in early cancer survivorship: a longitudinal study of haematological cancer patients.
Oberoi D et al. Eur J Haematol. 2017 Aug 21. doi: 10.1111/ejh.12941. [Epub ahead of print].
Novel Immunotherapies for Multiple Myeloma.
D’Agostino M et al. Curr Hematol Malig Rep. 2017 Aug 18. doi: 10.1007/s11899-017-0397-7. [Epub ahead of print].
Factors associated with second-line triplet therapy in routine care in relapsed/refractory multiple myeloma.
Hari P et al. J Clin Pharm Ther. 2017 Aug 17. doi: 10.1111/jcpt.12606. [Epub ahead of print].
Is early palliative care feasible in patients with Multiple Myeloma?
Porta-Sales J et al. J Pain Symptom Manage. 2017 Aug 11. pii: S0885-3924(17)30338-X. doi: 10.1016/j.jpainsymman.2017.04.012. [Epub ahead of print].
Economic burden of multiple myeloma among patients in successive lines of therapy in the United States.
MacEwan JP et al. Leuk Lymphoma. 2017 Aug 13:1-9. doi: 10.1080/10428194.2017.1361035. [Epub ahead of print].
Gender-Specific Aspects in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation: A Single-Center Experience.
Posch D et al. Oncology. 2017 Aug 12. doi: 10.1159/000478265. [Epub ahead of print].
Systemic virotherapy for multiple myeloma.
Oliva S et al. Expert Opin Biol Ther. 2017 Aug 10:1-13. doi: 10.1080/14712598.2017.1364359. [Epub ahead of print].
Host-related immunodeficiency in the development of multiple myeloma.
Dosani T et al. Leuk Lymphoma. 2017 Aug 9:1-6. doi: 10.1080/10428194.2017.1361026. [Epub ahead of print].
Feasibility of myeloablative allogeneic hematopoietic cell transplantation from unrelated donors for patients with relapsed or refractory multiple myeloma.
Shingaki S et al. Hematol Oncol. 2017 Aug 8. doi: 10.1002/hon.2470. [Epub ahead of print].
Lenalidomide: A Review in Newly Diagnosed Multiple Myeloma as Maintenance Therapy After ASCT.
Syed YY. Drugs. 2017 Aug 8. doi: 10.1007/s40265-017-0795-0. [Epub ahead of print].
Improved survival in Medicare patients with multiple myeloma: findings from a large nationwide and population-based cohort.
Chen Y et al. Med Oncol. 2017 Sep;34(9):153. doi: 10.1007/s12032-017-1001-7. Epub 2017 Aug 3.
Similar survival outcomes in patients with biclonal versus monoclonal myeloma: a multi-institutional matched case-control study.
Jurczyszyn A et al. Ann Hematol. 2017 Aug 1. doi: 10.1007/s00277-017-3084-9. [Epub ahead of print].
Coffee and Green Tea Consumption and Subsequent Risk of Malignant Lymphoma and Multiple Myeloma in Japan: The Japan Public Health Center-based Prospective Study.
Ugai T et al. Cancer Epidemiol Biomarkers Prev. 2017 Aug;26(8):1352-1356. doi: 10.1158/1055-9965.EPI-17-0231.
A new case of IgE multiple myeloma with review of literature.
Vignon G et al. Ann Biol Clin (Paris). 2017 Aug 1;75(4):442-444. doi: 10.1684/abc.2017.1263.
Cost-Effectiveness of Novel Agents in Medicare Patients with Multiple Myeloma: Findings from a U.S. Payer’s Perspective.
Chen Y et al. J Manag Care Spec Pharm. 2017 Aug;23(8):831-843. doi: 10.18553/jmcp.2017.23.8.831.
Oligoclonal Pattern/Abnormal Protein Bands in Post-Treatment Plasma Cell Myeloma Patients: Implications for Protein Electrophoresis and Serum Free Light Chain Assay Results.
Singh G. J Clin Med Res. 2017 Aug;9(8):671-679. doi: 10.14740/jocmr3049w. Epub 2017 Jul 1.